K.ChaoY
Small thing, but it matters.
Yes, enhanced monitoring is necessary including glucose parameters every 3 months, comprehensive metabolic panels every 36 months, periodic IGF-1 levels, and clinical surveillance for gastrointestinal symptoms, gallbladder disease, and growth hormone-related effects
Studies have demonstrated that Semaglutide not only decreases appetite but also enhances food intake regulation while reducing food cravings, in addition to improving glycemic control
Kate Good offers tailored weight loss plans (meal plans), compounded semaglutide injections, alongside aesthetic treatments such as Botox and dermal fillers
This explains one of the most common frustrations with GLP-1 therapy